Spots Global Cancer Trial Database for Selective Sentinella Lymph Node Biopsy With Indocyanine Green in Patients With Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Selective Sentinella Lymph Node Biopsy With Indocyanine Green in Patients With Breast Cancer
Official Title: Selective Sentinella Lymph Node Biopsy With Indocyanine Green in Patients With Breast.
Study ID: NCT06378944
Conditions
Study Description
Brief Summary: The current observational study aims to perform the sentinel lymph node in breast cancer in the usual way with technetium 99 and add a second tracer, indocyanine green. The objective is to evaluate the detection rate of the lymph node with indocyanine green compared to the usual technique.
Detailed Description: In the operating room 1 ml of indocyaninge grenn will be injectec periareolar . After 5 minutes the lymph node will be detected and extracted. The comparison between the lymph nodes detected with Technetium 99 and indocyanine green will be analysed.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Sandra Lopez Gordo, Cerdanyola Del Valles, Barcelona, Spain
Contact Details
Name: Sandra Lopez gordo
Affiliation: 46873584K
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
